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Background:  To  examine  immunisation  information  needs  of  teenagers  we explored  understandings
of  vaccination  and  vaccine-preventable  diseases,  attitudes  towards  immunisation  and  experiences  of
immunisation.  Diseases  discussed  included  nine  for  which  vaccines  are  currently  offered  in the  UK
(human  papillomavirus,  meningitis,  tetanus,  diphtheria,  polio,  whooping  cough,  measles,  mumps  and
rubella),  and two not  currently  included  in  the routine  UK  schedule  (hepatitis  B and  chickenpox).
Methods:  Twelve  focus  groups  conducted  between  November  2010  and  March  2011  with  59  teenagers
(29  girls  and  30 boys)  living  in various  parts  of  Scotland.
Results:  Teenagers  exhibited  limited  knowledge  and  experience  of  the  diseases,  excluding  chickenpox.
Measles,  mumps  and  rubella  were perceived  as severe  forms  of  chickenpox-like  illness,  and  rubella  was
not associated  with  foetal  damage.  Boys  commonly  believed  that  human  papillomavirus  only  affects  girls,
and both  genders  exhibited  confusion  about  its relationship  with  cancer.  Participants  considered  two  key
factors  when  assessing  the threat  of  diseases:  their  prevalence  in  the UK,  and  their  potential  to  cause  fatal
or long-term  harm.  Meningitis  was  seen  as  a threat,  but primarily  to babies.  Participants  explained  their
limited  knowledge  as  a result  of  mass  immunisation  making  once-common  diseases  rare  in the  UK,  and
acknowledged  immunisation’s  role in reducing  disease  prevalence.
Conclusions:  While  it is welcome  that  fewer  teenagers  have  experienced  vaccine-preventable  diseases,
this  presents  public  health  advocates  with  the  challenge  of  communicating  beneﬁts  of  immunisation
when  advantages  are  less  visible.  The  ﬁndings  are  timely  in view  of  the Joint  Committee  on Vaccina-
tion  and  Immunisation’s  recommendation  that  a booster  of meningitis  C vaccine  should  be offered  to
teenagers;  that  teenagers  did  not  perceive  meningitis  C as  a signiﬁcant  threat  should  be  a key  concern
of  promotional  information.  While  teenagers’  experiences  of  immunisation  in  school  were  not  always
thusiapositive,  they  seemed  en
. Introduction
Immunisation schedules are amended as new vaccines become
vailable and scientiﬁc knowledge increases [1]. Traditionally, few
accines have been offered to teenagers in most countries. For
ecades in the UK, tetanus and polio were the only vaccines offered
o 13-18 year olds to boost immunity to these infections throughout
dulthood; low dose diphtheria was added to this school-leavers’
ooster in 1994 [2]. In Wales, the only UK country to publish cov-
rage of the teenage booster, uptake is signiﬁcantly lower than
 This is an open-access article distributed under the terms of the Creative
ommons Attribution License, which permits unrestricted use, distribution, and
eproduction in any medium, provided the original author and source are credited.
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264-410X/$ – see front matter ©  2013 The Authors. Published by Elsevier Ltd. All rights 
ttp://dx.doi.org/10.1016/j.vaccine.2013.04.023stic  at the prospect  of  introducing  more  vaccines  for their  age group.
© 2013 The Authors. Published by Elsevier Ltd. All rights reserved.
vaccines given in early childhood (33.6% compared with 95%+) [3].
However, human papillomavirus (HPV) vaccine introduced in 2008
for 12-13 year old girls achieved almost 90% uptake in England [4]
indicating that immunisation of this age group is not only feasi-
ble, but can be highly successful. It has been suggested that other
vaccines should be included in the teenage vaccine programme,
for example booster doses of pertussis vaccine [1,5,6]. In January
2012 the Joint Committee on Vaccination and Immunisation (JVCI)
advised that a dose of Meningitis C vaccine be moved from the
infant to the teenage immunisation schedule [7]. In some areas,
MMR vaccine has been offered to teenagers who missed earlier
doses due to unsubstantiated fears over its safety, a major con-
cern in the 2000s, at the same time as the teenage booster [8,9].
The introduction of varicella and of hepatitis B vaccines have been
under consideration for some time by JCVI, with administration in
the teenage years a possible option [5,6].
Due to the success of immunisation, most teenagers have little
experience of vaccine-preventable diseases. This inexperience may
reserved.
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Table 1
Characteristics of focus groups and participants.
Focus group Recruited from Pseudonym Sex Age
1 Mixed area: Highland region Douglas Male 14
High school Anna Female 14
Eric Male 14
Victor Male 14
2 Mixed area: Highland region Struan Male 16
High school Ailsa Female 16
Sharon Female 16
Brenda Female 16
Vincent Male 16
Frank Male 16
3 Mixed area: Highland region Amy Female 15
High school Moira Female 15
Kenny Male 15
Dean Male 15
Diana Female 15
Naomi Female 15
4 Deprived area: West Lothian Alison Female 13
High school Lizzie Female 14
Vicky Female 13
Samantha Female 14
5 Deprived area: West Lothian Angus Male 14
High school Sula Female 13
Tina Female 14
Karl Male 15
6 Mixed area: Edinburgh Chloe Female 17
Youth Employment initiative Olivia Female 16
Stuart Male 17
Kieron Male 17
Tracy Female 17
Grace Female 16
7 Deprived area: Glasgow, East End Stacy Female 14
Youth group Quentin Male 18
Euan Male 17
Laura Female 16
Finn Male 17
David Male 15
Tony Male 14
Neil Male 16
Darren Male 15
8 Afﬂuent: Edinburgh Rebecca Female 17
Youth group Murray Male 14
Gary Male 13
Alan Male 15
9 Mixed: Renfrewshire Chris Male 15
Youth group Harry Male 15
Darren Male 15
Steven Male 15
Gayle Female 15
Daniele Female 15
10 Deprived: North Glasgow Lewis Male 15
Education support facility Edward Male 15
11 Mixed: Renfrewshire Struan Male 15
Youth group Rhea Female 15
Trisha Female 15
Veronica Female 15
12 Afﬂuent: Glasgow, West End Christine Female 17544 S. Hilton et al. / Vacc
oth increase the challenge of maintaining high coverage and focus
ttention on alleged adverse effects of immunisation [10]. Attitudes
o diseases and vaccines are important predictors of immunisation
ptake [11–13]. People’s vaccine decisions balance ‘complex and
ometimes contradictory’ concerns [14], including perceptions of
he risks and severity of diseases and the risks of vaccines [10].
lthough decision-making is routine for some [15,16], assessments
f risks or uncertainties associated with vaccines or diseases [17]
ften emerge after discussion with others [18], including health
rofessionals [10,16,19]. Understanding people’s knowledge of,
nd attitudes towards, vaccines and diseases is important in under-
tanding vaccine uptake.
A wealth of research has focused on parents’ attitudes towards
hildhood vaccinations [11,13,19–23], and some examining
arents’ knowledge and understanding of vaccine-preventable
iseases. In these studies meningitis, diphtheria, tetanus and
oliomyelitis are commonly perceived as severe, but rare
13,14,24–27]. Perceptions of the severity of measles are
nconsistent, with some studies reporting it to be considered
evere [13,14,27–29] and others mild [10,30]. Similarly, mumps
nd rubella are variously perceived as severe [14,29] or mild
24,26,27]. These contradictory ﬁndings may  arise from different
ethodological approaches, but there is broad agreement that
arental understanding of diseases is limited.
The few published studies investigating teenagers’ understand-
ng of vaccines and vaccine-preventable diseases have focused on
PV. These have found a general lack of awareness of the virus [31],
n particular its relationship with cervical cancer, even in young
omen who were the target of the high-proﬁle educational cam-
aign accompanying the vaccine’s introduction [25]. Hepatitis B is
lso little understood by teenagers [32], even in countries where
he vaccine is part of the routine infant schedule [33].
To our knowledge this is the ﬁrst UK study offering in-depth
ccounts from both young men  and women on a range of vaccine-
reventable diseases and their attitudes to immunisation. We  set
ut to explore teenagers’ understandings, beliefs and experiences
f nine diseases routinely vaccinated against (HPV, meningitis,
etanus, diphtheria, polio, whooping cough, measles, mumps  and
ubella) and two vaccine-preventable diseases that, it has been
uggested, should be added to the UK’s teenage immunisation pro-
ramme  (hepatitis B and chickenpox). We  also examined views
bout vaccination more generally, exploring personal experiences
f vaccination and negotiating consent, and views about whether
ore vaccines would be acceptable. With an expanding adoles-
ent vaccination programme, it is important to establish teenagers’
ttitudes and knowledge to guide information campaigns.
. Method
.1. Sampling and recruitment
Twelve focus groups were conducted between November 2010
nd March 2011 with teenagers aged between 13 and 18 liv-
ng in Scotland. Purposive sampling was used to recruit a sample
f diverse socio-economic background, geographical location, age
nd sex (see Table 1). Teenagers were recruited through posters,
eaﬂets and advertisements placed in settings including schools,
ommunity facilities and sport facilities. Advertisements inviting
nterested parties to contact the researcher (ES) were placed on
ebsites such as Facebook and Bebo. To allow recruitment from a
road range of socio-economic backgrounds, key community lead-
rs in socially deprived and advantaged areas were approached to
elp identify community groups. Groups predominantly consisted
f friendship groups. Each participant was given a £10 shopping
oucher to cover expenses and thank them for contributing.Youth group Deborah Female 17
Wendy Female 15
2.2. Data collection and analysis
Focus groups were facilitated by ES and carried out in local
community facilities. Discussions lasted between 45 and 80 min,
covering issues relating to participants’ understandings of diseases
and vaccines. In each group the researcher ﬁrst asked participants
about their vaccination histories since childhood, then prompted
ine 31 (2013) 2543– 2550 2545
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Box 1: The discomfort caused by vaccination has been
exaggerated
Sharon: Until I had that last jag, the HPV I had, I imagined
them (the needle) being quite a big thing. . .
Ailsa: Yeah so did I.
Sharon: . . .but actually, now, like I think before that, like,
any jags I’d had, when I was young, I didn’t really
understand what was going on. But since I’m kind
of. . . I’m older and I kind of saw that one, then I
realised that the needle’s actually quite small and
they’re not as big as I’d imagined they were.
Facilitator: Yeah.
Ailsa: I found it helped a lot. Actually, I found with the
HPV ones as well, I mean, when I got my ﬂu one
done, I didn’t actually care all that much.  Ok, it
stung a wee bit, but it wasn’t that bad. I mean, it
was just kind of like, it felt like a wee  tiny paper
cut and that was it. But I mean, I can actually just
sit there and watch the needle going in, but with-
out any problem or anything whereas, when I was
younger, I would have been screaming.S. Hilton et al. / Vacc
hem to describe their understandings of speciﬁc diseases and their
ymptoms, and ﬁnally prompted them to discuss their experiences
f, and attitudes towards, vaccinations. With participants’ permis-
ion, discussions were audio-recorded and transcribed verbatim.
ach transcript was checked and imported into NVivo 8 to enable
ystematic comparisons to be made across the large amount of data.
ata were thematically coded and systemically charted following
ramework analysis principles [34], allowing data to be rigorously
xamined and cross-compared to identify common reasoning and
hemes, and ideas that are less common or are speciﬁc to certain
ubgroups or individuals. Themes were coded by ES and CP and
hecked by SH. Final analysis of frameworks was conducted by
P and SH. During analysis, attention was paid to deviant or con-
radictory cases [35] and to group dynamics, using full transcripts
upplemented by ﬁeld-note observations [36].
.3. Reporting data
To report data we selected concisely-expressed quotations that
ypify responses around key themes, and some discussion extracts
hat convey the types of group interactions that occurred. Focus
roup methods can generate dynamic data by encouraging discus-
ion between group members [37]. Chaotic conversations in more
nimated groups can make individual speakers difﬁcult to identify;
eld notes taken during the discussions facilitated identiﬁcation of
peakers. Participants have been assigned pseudonyms to contex-
ualise contributions while preserving anonymity.
Ethics approval was obtained from the research ethics commit-
ee of the University of Glasgow’s Law, Business and Social Sciences
aculty.
. Results
Fifty-nine teenagers (29 girls and 30 boys) aged between 13 and
8 years old took part in 12 focus group discussions (Table 1). Par-
icipants were asked about their immunisation history. Forty-six
ad been vaccinated as teenagers with HPV, Td/IPV or a travel vac-
ine; 13 had received no vaccinations. Of those 13, four had not
een offered vaccinations as teenagers, six had accidentally missed
accines and three had decided, with their parents, to refuse vac-
ines. Two participants had never received any vaccinations due to
heir parents’ beliefs about immunisation.
With the exception of chickenpox, participants typically had lit-
le or no direct experience of the diseases discussed, except for one
ho recalled contracting mumps  (Lizzie, FG4), and another whoop-
ng cough (Olivia, FG6). Most participants’ views about diseases
herefore derived from indirect experiences. Participants were gen-
rally uninquisitive about vaccine-preventable diseases, with only
wo describing actively seeking information, from the Internet
Olivia, FG6) and their doctor (Tracy, FG6).
.1. Perceptions of diseases
When assessing how threatening a disease is, participants
ended to talk about two key factors: its prevalence in the UK
nd whether it could be fatal or cause long-term, debilitating and
rreversible damage. Perceptions of risk were typically mediated
y two factors: geographical location, and contemporaneousness.
articipants frequently deemed diseases to represent threats in
ess developed countries, but not in the UK; one girl observed:
can you not just die from all of them if you were in like living
n Africa or somewhere like that?’ (Daniele, FG9). Similarly, par-
icipants frequently perceived diseases as historical threats that
re no longer relevant. As one girl explained, ‘It’s been more like
hings that are more serious like in the past and now . . . peopleGroup 2
are more protected against them’ (Rebecca, FG8). Diseases associ-
ated with less developed countries or the past included tetanus,
diphtheria, poliomyelitis, whooping cough, and tuberculosis. Par-
ticipants described these as from ‘the past’, ‘the war’ (Murray, FG8)
and ‘Victorian times’ (Steven FG9). One associated poliomyelitis
with the ‘1940s’, corresponding with the outbreak of that decade.
Explanations for reduced threat in contemporary Britain included
successful mass immunisation programmes, advances in medicine
and improvements in living conditions. Participants believed those
diseases could be threatening again if immunisation was to cease.
Participants’ awareness and understandings of each disease dis-
cussed are detailed in Table 2.
3.2. Understandings and concerns about immunisation
Advantages and disadvantages of immunisation were discussed.
Participants expressed varied views about whether immunisa-
tion is a positive or negative intervention. Just over half of the
participants presented positive images of vaccines protecting the
population against disease. Wendy (FG12) stated: “It has been
proved to, like, get rid of, or practically get rid of some diseases,
like, in the population – so that’s a positive thing”. Most partic-
ipants displayed high trust in vaccines and little concern about
side-effects. Participants discussing side-effects tended to focus on
short-term rather than long-term effects, typically discomfort sur-
rounding the administration of vaccines. Long-term side effects
mentioned included fertility problems (Rebecca FG8; Laura FG7),
negative effects on the immune system (Murray, Alan FG8) and
reduced resistance to diseases being vaccinated against (Quentin
FG7). Conversations about vaccinations were dominated by images
of needles and the fear and pain associated with receiving injec-
tions. When elaborating on thoughts about needles and injections,
participants often used negative language, describing them as
‘painful’ (Lewis FG8), ‘scary’ (Alison FG4), ‘sharp’ (Laura FG7) and
‘dagger-like’ (Rebecca FG8). Although many participants described
their anxieties about injections at length, three groups discussed
the notion that the unpleasantness of vaccinations tends to be exag-
gerated (see Box 1).
Some participants were extremely worried by vaccinations. One
participant, who  also explained that she did not feel a responsibility
2546 S. Hilton et al. / Vaccine 31 (2013) 2543– 2550
Table 2
Participants awareness and understandings of vaccine-preventable diseases.
Disease Awareness of disease Understanding of disease process and symptoms
Diseases viewed as most threatening:
Meningitis Most had heard of meningitis, and perceived it as severe and
quite prevalent.
Not typically seen as a particular risk to teenagers; babies
believed to be at greatest risk, due being the focus of a Men  C
public information campaign.
Almost half of participants described symptoms they
associated with meningitis, including: skin lumps and rashes;
throat problems; muscle pain; and blindness. Participants
mentioned a television campaign promoting the “tumbler test”
to  identify whether a rash is suggestive of meningococcal
septicaemia.
Hepatitis B Participants had typically heard of hepatitis B but claimed no
knowledge of it. They regarded it as causing debilitating,
long-term damage.
Commonly associated with drug abusers.
Participants offered relatively accurate descriptions of
transmission when prompted, associating it with sexual
transmission and infected blood from ‘sharing dirty needles’
and ‘bad tattoos’ (Stuart, FG6).
Participants were reluctant to guess symptoms.
HPV  Girls typically demonstrated some awareness of HPV and
many had recently been vaccinated against it. Boys
demonstrated relatively little awareness.
Participants typically perceived it as a prevalent infection, and
many viewed it as a serious disease.
Boys commonly believed the virus only affects females. Some
girls expressed similar beliefs: ‘I don’t think [boys] can catch
HPV very easily’ (Tina, FG5).
Doubts that HPV can infect males coexisted paradoxically with
widespread recognition that it is transmitted sexually.
Some demonstrated confusion about the association between
HPV and cancer (see Box 3).
Diseases of uncertain threat:
Measles Typically believed to be in circulation within the UK, but
unlikely to be contracted.
Participants evenly divided between those who  believed
measles can cause long-term damage and those who  believed
it  to be mild.
Many offered accurate descriptions of symptoms: itchy red
spots and rashes; swelling; and fever.
Commonly confused with chickenpox; some suggested it may
be  a more severe form (see Box 4).
Mumps  Participants unsure whether mumps is in circulation in the UK.
Some believed it to be extremely prevalent.
One girl described mumps  as an ‘old fashioned disease’ (Trisha,
FG11)
Participants evenly divided between those who  believed
mumps  to be severe and those who did not.
Mumps  was commonly correctly associated with glandular
swelling. Some incorrectly suggested that it causes
chickenpox-like rashes on the skin.
One boy believed that mumps is primarily contracted by males.
Rubella Few had heard of rubella or German measles. Those who attempted to describe symptoms mentioned
irritating spots, a chickenpox-like rash, muscular problems
and swelling of the face and neck. Some believed it may be
‘like a severe case of chickenpox’ (Chloe FG6, Darren FG9,
Christine FG12).
No participants described the mode of transmission or
acknowledged the risk of foetal damage.
Diseases viewed as least threatening:
Tetanus Commonly viewed as a historical threat. Few participants claimed to know the symptoms of tetanus.
Two correctly associated it with lockjaw (Murray FG8, Douglas
FG1).
Participants accurately associated tetanus with wounds
coming into contact with bacteria, but few knew the
environmental conditions in which the organism lives.
Suggested locations included rust and rusty metal, used
needles, broken glass, and animal bites. Two correctly
associated it with soil, but incorrectly linked it to rust.
Diphtheria Most had heard of diphtheria.
Typically perceived as an historical disease, but many were
aware that they had been, or would in future be, vaccinated
against it, and so wondered if it might still be in circulation.
None could describe its symptoms, and participants were
particularly reticent to offer descriptions of its transmission.
Poliomyelitis Most had heard of poliomyelitis, typically referring to it as
‘polio’.
Awareness associated with having recently been vaccinated
against it.
Widely viewed as a historical threat, and associated with less
developed countries.
It was generally associated with leg-related skeletal problems,
including being wheelchair-bound and one leg being longer
than the other. No participant mentioned respiratory muscle
paralysis.
Few could describe its transmission.
Whooping cough Fewer than half were aware of being vaccinated against
whooping cough.
Generally not considered to be a threat to people living in the
UK.
Commonly described as a severe cough and sometimes
associated with coughing up blood or ‘black mucus’.
No participants recognised that it can be fatal.
Chickenpox Generally seen as a routine and trivial part of childhood, only
problematic if contracted in adulthood.
Participants who had not yet experienced chickenpox
expressed anxiety about contracting it in future: ‘I’ve never
had it. I don’t want to get it when I’m older, you can die.’ (Chris,
FG9).
Participants tended to describe signs and symptoms of
chickenpox accurately. It was seen as very contagious and
mild, and associated with itchy red spots on the skin that can
leave pock marks.
S. Hilton et al. / Vaccine 31 (2013) 2543– 2550 2547
Box 2: The usefulness of a vaccine depends on the dis-
ease it prevents
Kenny: Chickenpox vaccine wouldn’t really beneﬁt most
people. . .
Diana: I would.
Kenny: . . . ‘cos most people have had the disease already.
Diana: Yeah. I would, I would accept chickenpox vaccine, but
hepatitis B you only tend to get if you’re on holiday,
well it’s, you’re much  more likely to get it when you’re
away
Group 3
Samantha: I dinnae see the point in them.
Sammy: I don’t see the point in getting a vaccine for
chicken pox either.
Facilitator: How come?
Sammy: Because it’s just a little rash that you’re coming
out in, when you get it, and it just disappears.
Samantha: It’s no very severe. You just itch when you get it.
Alison: I’d say get one for hepatitis B because that’s like
something serious to dae wi’ your liver.
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Box 3: Girls’ understandings of, and confusion about,
HPV
Facilitator: So what do you know about human papillomavirus
that you get the HPV vaccine for?
Rhea: is that not like cancer, and like anyone can get can-
cer?
Trisha: No, is that not a gene? Like girls, like any girl could
get that.
Rhea: Hang on, how do you get HPV? Because is cancer
not through genes, but then. . .
Trisha: I think it’s just like cancerous cells
Rhea: Is it?
Veronica: Yeah, it’s like cancerous cells and tumours, and then
you die.
Group 11
Deborah: Oh. . . it gives cervical cancer.
Wendy: Cervical cancer.
Deborah: It’s sexually transmitted. You’re more likely to get it
if you sleep around.
Wendy: It’s a cancer in the womb. Yeah.
Deborah: You get screened for it. Women get screened for it
when they’re older, and only women  can get it.Group 4
o be immunised because she had no dependents, stated: ‘I’d rather
ie in my  sleep than have a jag’ (Samantha, FG4). Another did not
erceive the beneﬁts as outweighing the costs, stating: ‘I’d rather
ave cancer than get a very painful, numb arm I’ll actually kill my
um if she makes me  get another one’ (Sula, FG5).
Participants were asked about receiving newly-introduced vac-
ines and combination vaccines. Discussions about combined
accines tended to conclude that they are preferable as they reduce
he overall number of injections needed, as illustrated in Kenny’s
FG3) comment that “. . .the fewer, the better as far as I’m con-
erned”. Most groups responded positively to the suggestion of new
accines being introduced to the school immunisation programme.
ocus Group 9 typiﬁed these discussions:
Chris: I’d be delighted.
Harry: The more the merrier.
Gayle: It’s going to help you, like if it’s going to help you, you
might as well get it.
Chris: It’s for your good.
aniele: I think any jag would be good to get.
Darren: Unless it’s one of those massive needles (laughs)
Some were wary of new vaccines. One stated: “. . .they may  have
nknown side-effects if they’ve not been tried on people. . .like you
on’t know what could happen in the long-term (Rebecca, FG8).
articipants mentioned that they did not like being ‘used as guinea
igs’ (Veronica, FG11; Karl FG5; Amy  FG3). While most participants
ere prepared to accept new vaccines regardless of the disease
argeted, others considered whether speciﬁc diseases merited vac-
ination (see Box 2).
.3. Beliefs about choice and responsibility
Participants were encouraged to discuss issues of choice and
esponsibility related to vaccination. Two positions were com-
only presented: choice about vaccinations is desirable, and
niversal immunisation is advantageous. Some regarded choice as
ssential, while acknowledging the utility of vaccinations: “Refus-
ng vaccinations is just silly. . . . But if there was  a reason whyGroup 12
a mother didn’t want their child to have that vaccination, they
shouldn’t be forced to’ (Moira, FG3).” Steven (FG9) suggested: ‘it
is good that it’s voluntary because like you’re not actually forced
into it . . . you can actually make your own  decision.’ A partici-
pant who had opted out of vaccination against HPV felt that those
who opt out can experience pressure due to social expectations:
‘Some people might still feel like because the majority maybe
do get it, they might still feel pressured or feel like, you know,
why are you not? . . . There’s still quite an expectation for you
just to get it.’ (Rebecca, FG8). It was  suggested that promoting
vaccinations as a social responsibility may  make those who opt
out feel guilty. Some described those who opt out of as “lazy”
(Chris FG9), “stupid” (Daniele FG9) and “selﬁsh” (Wendy FG12).
However, the same participants recognised that there were legit-
imate reasons to opt out on medical or religious grounds. Some
respondents believed compulsory vaccinations could generate
opposition to vaccine acceptance in reaction to the lack of choice.
Participants in most groups recognised vaccination as beneﬁcial to
society as well as the individual. Eric (FG1) believed that: “. . .people
have a responsibility to receive vaccines if they want to keep them-
selves safe and not pass it on to the others”. There was little
acknowledgement that some people cannot receive vaccines.
3.4. Experiences of vaccination and decision-making
Not all participants’ experiences of receiving vaccines were neg-
ative (Box 1). Participants in one group discussed an unexpectedly
straightforward vaccination experience in which the immuniser
engaged the student in conversation while performing the injec-
tion, which made the process more pleasant than anticipated.
Participants discussed circumstances of vaccinations adminis-
tered in school. Participants in Focus Group 1 expressed concerns
about privacy, personal space and the potential discomfort of being
watched by peers during vaccination. Students described a fellow
pupil who  had to remove her shirt to receive a vaccine, which was
agreed to be an undesirable experience. While some participants
disliked being watched, others described witnessing vaccination in
others as similarly distressing: “It’s not good because you can see
2548 S. Hilton et al. / Vaccine 31
Box 4: Associations drawn between measles and chick-
enpox
Facilitator: So what sort of things come to mind when you say
measles?
Frank: Is it not kind of like chickenpox, maybe.
Brenda: A worse case, or it affects you in different places com-
pared to chickenpox.
Group 2
Karl: Spots on your skin or something.
Angus: Kind of like chickenpox.
Group 5
Olivia: Are they not like, they’re a bit like chickenpox little
spots or something?
Grace: But what are chickenpox then?
Group 6
Rebecca: . . . is that not a bit like chickenpox?
Murray: More serious though.
Group 8
Struan: It’s related to the mumps.
Rhea: I just know ‘cats got the measles’.
Veronica: Is it like, I thought it was related to chickenpox? I
thought they had some similarities.
Group 11
Christine: Am I right in saying you can only get measles once
you’ve had chickenpox?
Wendy: I think of a bad temperature.
Deborah: Measles is more, and it lasts longer as well.
Christine: Measles is more an adult thing and chickenpox is
a child thing.
Deborah: and it’s more severe.
Christine: Yes.
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more becoming available. However, given the nature of recruitmentGroup 12
veryone else getting theirs done, and you’re thinking, ‘oh, that’s
hat’s going to happen to me’  and you start to freak out” (Deborah,
G12).
Some responsibility for generating anxiety was attributed to
hose administrating the vaccines. One participant stated: “my
iggest worry is just knowing that I’m in safe hands as I don’t know
hem from Adam” (Kieron, FG6). Another complained that: “you’re
etting a jag and they’re telling you about more jags, it’s ‘I don’t
ant to hear about more jags”’ (Samantha, FG4). Some with par-
icular anxieties had opted to receive vaccines at their GP surgery,
ather than in school, although they also acknowledged it would be
mpractical to deliver the whole programme in that way  (Ailsa FG
). Mild side-effects of vaccination were described. For most par-
icipants anxiety was the most signiﬁcant concern, causing them
o feel sick, faint, tearful or unable to concentrate on schoolwork
Brenda, FG2, Deborah FG12, Sammy, FG4).
Participants were encouraged to discuss the process of deciding
hether to receive vaccinations or not. Some discussed vaccina-ions with their parents and felt able to inﬂuence the decisions:
mum says it was up to me  if I wanted it or not” (Eric, FG1).
owever, participants more commonly felt that the decision was (2013) 2543– 2550
ultimately taken by their parents, primarily mothers. Participants
typically acknowledged they could contribute to the process, but
many viewed it as a false choice, in which the only legitimate option
was to agree. Anna (FG1) typiﬁed this, explaining: “my  mum  will
probably just say ‘do you want it?’ and I’ll be like ‘not really’ but
she’ll just sign it (consent form) anyway no matter what”.
4. Discussion
To our knowledge this is the ﬁrst UK study investigating
in-depth the understandings, attitudes and experiences of
teenage boys and girls regarding a range of vaccines and
vaccine-preventable diseases. The broad ﬁnding that teenagers’
understandings of vaccine-preventable diseases are limited is in
line with previous research [25,27,38–41]. This study identiﬁes
many of the same gaps in understanding as previous research with
parents of young children [27], supporting the conclusion that
understanding of diseases is closely related to experience of dis-
eases. This is illustrated by the ﬁnding that chickenpox was  both
the most commonly experienced and widely understood disease
discussed. This supports the suggestion that successful immunisa-
tion has reduced knowledge of diseases, their severity and possible
long-term consequences [10,42].
Teenagers often referred to chickenpox when describing other
diseases about which they knew little. For example they imag-
ined that measles, mumps  and rubella might resemble severe cases
of chickenpox. Rubella was not associated with the risk of foetal
damage, and participants were divided about the severity of both
mumps  and measles, echoing previous research [10,13,14,27,29].
Participants (particularly girls) were most aware of HPV infection
but it was nonetheless subject to misunderstandings; boys com-
monly believed it to only affect girls, and both sexes demonstrated
confusion about its relationship with cervical cancer, again echoing
existing research [25,40,41,38,43]. As HPV infection is complex and
fundamentally different from other vaccine-preventable diseases,
so misunderstandings are not surprising. However, as the primary
aim of HPV vaccination is the prevention of cervical cancer, this is
somewhat disappointing. Many female participants had received
the vaccine relatively recently, and should have been availed of
this information. This emphasises the need to develop information
that meets this young audience’s speciﬁc needs.
In contrast to studies where teenagers demonstrated low
awareness of hepatitis B [32,33,39,38], our participants displayed
relatively good knowledge of its transmission, and perceived it
as a threat. When assessing which diseases were most threat-
ening, participants mentioned two  key factors: its prevalence in
the UK, and whether it could be fatal, debilitating, or cause long-
term harm. In line with previous research [11,28], some of the
participants’ vaccine decision-making seemed to be strongly inﬂu-
enced by perceptions of disease severity, emphasising the need for
clear information. Many diseases were seen as historical, and no
longer threats in the UK, complementing ﬁndings of research with
parents [27]. While meningitis was  considered one of the more
life-threatening diseases, teenagers tended to think only babies
were at heightened risk. Since teenagers are at greater risk than
babies of a poor outcome from Meningococcal C infection [44],
this is concerning. This misconception is particularly relevant as
the JCVI have recommended a dose of Meningococcal C vaccine
be offered to all teenagers, and information about it will need to
feature prominently in accompanying information.
Overall the participants were very aware of vaccines’ impact on
reducing diseases, and some were enthusiastic at the prospect ofto the study, our ﬁndings may  not be representative of all adoles-
cents, and may  reﬂect the views of more enthusiastic or interested
teenagers.
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The teenage years are a key opportunity to promote vacci-
ation to future parents. For example, some of the participants
xpressed concern that they may  be ‘guinea pigs’ for new vac-
ines, echoing concerns found in studies of parental attitudes [45].
s such, improving teenagers’ understandings of how vaccines
re developed, introduced and monitored could beneﬁt vaccine-
elated decision making and uptake throughout life.
Our ﬁndings also revealed that although teenagers are encour-
ged to make decisions about immunisation, the decision is often
ade by parents, particularly mothers. Parents may  view the pro-
ess differently; in one study of 300 parents of 11-12 year olds
ost felt that decisions about vaccines should be made jointly
ith parents, but almost half agreed that a well-informed child
hould be able to request vaccines without parental consent [20].
he teenage years are an ideal time for parents to involve children in
aking health-related decisions, particularly since 16-18 year olds
re legally entitled to consent to treatment, and under-16s who
an demonstrate they fully understand the proposed intervention
an also give consent (“Gillick” competent). It is unclear to what
xtent parents understand this, but guidance on consent has been
peciﬁcally developed for them [46].
For many participants the administration of vaccines repre-
ented the greatest source of worry. This is important information
or vaccine providers; efforts must be made to deliver school-based
accination in ways which take teenagers concerns seriously and
educe anxiety and negative experiences. One study [3] reported
hat signiﬁcantly higher uptake of teenage boosters has been
chieved when administered in schools, compared with in gen-
ral practice, and another [47] found that combining the delivery
f HPV vaccine for girls with the teenage booster for girls and boys
esulted in higher uptake of both, and a mutually-supportive atmo-
phere among recipients. This is reassuring given the forthcoming
ddition of Meningitis C vaccine to the adolescent schedule, which
ill require teenagers to receive more than one vaccine at time.
Although a total of 59 young people were included in this study,
nd particular effort was made to include teenagers from diverse
ocio-economic backgrounds and geographical locations in Scot-
and, no students from ethnic minority backgrounds took part,
hich may  limit the generalisability of the ﬁndings to the wider
K population. Nevertheless, the ﬁndings give important insights
nto teenagers’ understandings, attitudes and experiences. In future
esearch it will be useful to establish whether the belief that menin-
itis is most risky for babies is widely held. No clear differences in
nderstandings and experiences based on socioeconomic status,
ge or sex emerged from the data.
. Conclusions
These young people will be the next generation of parents. Offer-
ng additional vaccines to adolescents provides a real opportunity
o build their conﬁdence and knowledge about the value of vac-
ines, which may  in turn positively inﬂuence their future decisions
or their own children.
Our ﬁndings contribute to a body of literature highlighting a lack
f public understanding of diseases that have become uncommon
ue to successful mass immunisation. This presents public health
nd immunisation promoters with the challenge of communicat-
ng the beneﬁts of immunisation at a time when the advantages
re less visible. While it is fortunate that teenagers have little per-
onal experience of vaccine-preventable diseases, it contributes to
he challenge of developing ways to engage with them to increase
heir understanding and awareness of the threats posed by vaccine-
reventable diseases, so that they are accepting of vaccines for
hemselves and will be able to make informed choices about
mmunisation for their own children as the parents of tomorrow.
[
[ (2013) 2543– 2550 2549
Acknowledgements
We would like to thank all the teenagers who kindly agreed
to take part in the study and the gatekeepers who  facilitated the
organisation of groups.Contributors: HB conceived the idea for the
study and participated in re-drafting the manuscript. SH partic-
ipated in the design, analysis, and drafting all versions of the
manuscript. CP participated in the analysis and helped draft the
manuscript. ES collected the data. KH participated in the design
and in re-drafting the manuscript. All authors approved the ﬁnal
manuscript.
Conﬂict of interest: We  have no competing interests.
Funding: This study was  funded by the Medical Research Coun-
cil and the Chief Scientist Ofﬁce of the Scottish Government Health
Directorates for work in the Understandings and Uses of Public
Health Research programme (MC  US A540 5TK70). The funding
body had no role in the design, collection analysis or interpretation
of this study.
References
[1] Pollard AJ. Childhood immunisation: what is the future? Arch Dis Child
2007;92(5):426–33.
[2] Maple P, Jones CS, Wall EC, Vyse A, Edmunds WJ,  Andrews NJ, et al. Immunity
to  diphtheria and tetanus in England and Wales. Vaccine 2000;19(2):167–73.
[3] Crocker J, Porter-Jones G, McGowan A, Roberts RJ, Cottrell S. Teenage booster
vaccine: factors affecting uptake. J Public Health 2012;34(4):489–504.
[4] Department of Health. Annual HPV vaccine coverage in England in 2011/12
report; 2013 [cited; Available from: http://immunisation.dh.gov.uk/ann-hpv-
vac-cover-england-201112/].
[5] Finn A, Clarke E, Mytton J. Adolescent immunisation: the next big thing? Arch
Dis Child 2010;96(6):497–9.
[6] Kale AR, Snape MD.  Immunisation of adolescents in the UK. Arch Dis Child
2011;96(5):492–5.
[7] Joint Committee on Vaccination and Immunisation. JCVI statement on the use of
meningococcal C vaccines in the routine childhood immunisation programme;
2012.
[8]  Paranthaman K, Bunce A. Opportunistic MMR  vaccination for unimmunized
children at the time of routine teenage booster vaccination in secondary
schools: implications for policy. Epidemiol Infect 2012;140(9):1612.
[9] Lashkari HP, El Bashir H. Immunisations among school leavers: is there a
place for measles-mumps-rubella vaccine? Editorial Team Editorial Board
2010;15(17):1–3.
10] Yarwood J, Noakes K, Kennedy D, Campbell H, Salisbury DM.  Tracking mothers
attitudes to childhood immunisation 1991–2001. Vaccine 2005;23:5670–87.
11] Peckham C, Bedford H, Senturia Y, Ades A. The Peckham report: national
immunisation study: factors inﬂuencing immunisation uptake in childhood.
London, Horsham: Action for the Crippled Child; 1989.
12] Duffell E. Attitudes of parents towards measles and immunisation after a
measles outbreak in an anthroposophical community. J Epidemiol Commun
Health 2001;55:685–6.
13] Smailbegovic MS,  Laing G, Bedford H. Why  do parents decide against immu-
nization? The effect of health beliefs and health professionals. Child Care Health
Dev 2003;29:303–11.
14] Flynn M,  Ogden J. Predicting uptake of MMR  vaccination: a prospective ques-
tionnaire study. Br J Gen Pract 2004;54(504):526–30.
15] Streeﬂand P, Chowdhury AM,  Ramos-Jimenez P. Patterns of vaccination accep-
tance. Soc Sci Med  1999;49(12):1705–16.
16] Brownlie J, Howson A. ‘Leaps of Faith’ and MMR:  an empirical study of trust.
Sociology 2005;39(2):221–39.
17] Hobson-West P. ‘Trusting blindly can be the biggest risk of all’: orga-
nised resistance to childhood vaccination in the UK.  Sociol Health Illn
2007;29(2):198–215.
18] Poltorak M,  Leach L, Fairhead J, Cassell J. “MMR  talk’ and vaccination choices:
an ethnographic study in Brighton. Soc Sci Med  2005;61:709–19.
19] Ramsay M,  Yarwood J, Lewis D. Parental conﬁdence in measles, mumps  and
rubella vaccine. Br J Gen Pract 2002;52(484):912–6.
20] Brabin L, Roberts SA, Farzaneh F, Kitchener HC. Future acceptance of adoles-
cent human papillomavirus vaccination: a survey of parental attitudes. Vaccine
2006;24(16):3087–94.
21] Smith A, Yarwood J, Salisbury DM.  Tracking mothers’ attitudes to MMR  immun-
isation 1996–2006. Vaccine 2007;25(20):3996–4002.
22] Stretch R, Roberts SA, McCann R, Baxter D, Chambers G, Kitchener H, et al.
Parental attitudes and information needs in an adolescent HPV vaccination
programme. Br J Cancer 2008;99(11):1908–11.
23] Zimet GD, Mays RM,  Sturm LA, Ravert AA, Perkins SM,  Juliar BE. Parental atti-
tudes about sexually transmitted infection vaccination for their adolescent
children. Arch Pediatr Adolesc Med  2005;159(2):132–7.
2 ine 31
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[550 S. Hilton et al. / Vacc
24] Bond L, Nolan T, Pattison P, Carlin J. Vaccine preventable diseases and immuni-
sations: a qualitative study of mothers’ perceptions of severity, susceptibility,
beneﬁts and barriers. Aust N Z J Public Health 1998;22:440–6.
25] Hilton S, Smith E. “I thought cancer was  one of those random things. I
didn’t know cancer could be caught. . .”: adolescent girls’ understandings
and experiences of the HPV programme in the UK. Vaccine 2011;29(26):
4409–15.
26] Sporton RK, Francis S. Choosing not to immunize: are parents making informed
decisions? Fam Pract 2001;18(2):181–8.
27] Hilton S, Hunt K, Petticrew M.  Gaps in parental understandings and experi-
ences of vaccine-preventable diseases: a qualitative study. Child Care Health
Dev  2007;33(2):170–9.
28] Bedford H, Lansley M.  More vaccines for children? Parents’ views. Vaccine
2007;25(45):7818–23.
29] Pareek M,  Pattison HM.  The two-dose measles, mumps, and rubella (MMR)
immunisation schedule: factors affecting maternal intention to vaccinate. Br J
Gen Pract 2000;50:969–71.
30] Gellin BG, Maibach EW,  Marcuse EK. Do Parents understand immunizations?
A  national telephone survey. Pediatrics 2000;106(5):1097–102.
31] Marlow L, Waller J, Wardle J. Public awareness that HPV is a risk factor for
cervical cancer. Br J Cancer 2007;97(5):691–4.
32] Hinds A, Cameron J. Acceptability of universal hepatitis B vaccination
among school pupils and parents. Commun Dis Public Health 2004;7(4):
278–82.
33] Slonim AB, Roberto AJ, Downing CR, Adams IF, Fasano NJ, Davis-Satterla L, et al.
Adolescents’ knowledge, beliefs, and behaviors regarding hepatitis B: insights
and implications for programs targeting vaccine-preventable diseases. J Ado-
lesc  Health 2005;36(3):178–86.
34] Ritchie J, Spencer L. Carrying out qualitative analysis. Qualitative research
practice: a guide for social science students and researchers. London: Sage;
2003.
35] Bloor M,  Frankland J, Thomas M,  Robson K. Focus groups in social research.
London: Sage; 2001.
36] Kitzinger J. The methodology of focus groups: the importance of interaction
between research participants. Sociol Health Illn 1994;16(1):103–21.
[ (2013) 2543– 2550
37] Barbour R, Kitzinger J. Developing focus group research: politics theory and
practice. London: Sage Publications; 1999.
38] Clark LR, Jackson M,  Allen-Taylor L. Adolescent knowledge about sexually trans-
mitted diseases. Sex Transm Dis 2002;29(8):436–43.
39] Butler LM,  Mills PK, Yang RC, Chen Jr MS. Hepatitis B knowledge and vaccina-
tion levels in California Hmong youth: implications for liver cancer prevention
strategies. Asian Pac J Cancer Prev 2005;6(3):401–3.
40] Woodhall SC, Lehtinen M,  Verho T, Huhtala H, Hokkanen M,  Kosunen E. Antic-
ipated acceptance of HPV vaccination at the baseline of implementation: a
survey of parental and adolescent knowledge and attitudes in Finland. J Adolesc
Health 2007;40(5):466–9.
41] Pelucchi C, Esposito S, Galeone C, Semino M,  Sabatini C, Picciolli I, et al. Knowl-
edge of human papillomavirus infection and its prevention among adolescents
and  parents in the greater Milan area, Northern Italy. BMC  Public Health
2010;10:378.
42] Hilton S, Petticrew M,  Hunt K. ‘Combined vaccines are like a sudden onslaught
to  the body’s immune system’: parental concerns about vaccine ‘overload’ and
‘immune-vulnerability’. Vaccine 2006;24(20):4321–7.
43] Bynum SA, Wright MS,  Brandt HM,  Burgis JT, Bacon JL. Knowledge, beliefs,
and  attitudes related to human papillomavirus infection and vaccination, pap
tests, and cervical intraepithelial neoplasia among adolescent girls and young
women. J S C Med  Assoc 2009;105(7):267–72.
44] Miller E, Salisbury D, Ramsay M.  Planning, registration, and implementation of
an  immunisation campaign against meningococcal serogroup C disease in the
UK: a success story. Vaccine 2001;20:S58–67.
45] Parrella A, Gold M,  Marshall H, Braunack-Mayer A, Baghurst P. Parental
perspectives of vaccine safety and experience of adverse events following
immunisation. Vaccine 2013;31(16):2067–74.
46] Department of Health. Consent – what you have a right to expect: a guide
for parents; 2001 [cited; Available from: http://www.nhs.uk/NHSEngland/
AboutNHSservices/Documents/Consent %20aguideforparentsDH 4117353.
pdf].
47] Gordon J, Lansley M,  Mitchell D. Combining the delivery of the human
papillomavirus vaccine and the Td/IPV teenage booster (2kb). Br J Sch Nurs
2013;8(1):20–4.
